|
Of interest to balding nephrologists only. |
|
|
|
ABC news: The authors suggest that temporarily blocking CRF receptors could be "a breakthrough therapy for alopecia," and might also hold potential for male pattern baldness and hair loss due to chemotherapy. "What we can reasonably say is that the antagonist initiates the hair cycle," Million said. "In bald individuals, and in these mice, the hair follicles are in a resting stage. The antagonist awakes them. It turns on the cycle, and the growing phase starts." The treatment not only reversed hair loss, it also prevented it if started ahead of time. It also restored pigmentation in the skin -- an effect Million said might prevent graying too.
|